Item 7.01 Regulation FD Disclosure.
On November 7, 2022, Know Labs, Inc. (the “Company”) announced it would present
at the second annual Bernstein CGM Disruptors Conference, Friday, November 18,
2022. At this virtual event organized by Bernstein Research,
https://ift.tt/fDzvMhL, attendees from across the globe will gather to
discuss new developments in continuous glucose monitoring technology. On
November 16, 2022, the Company released the presentation it will deliver at the
conference. The presentation is furnished as Exhibit 99.1 to this report and can
also be downloaded on the Company website, http://www.knowlabs.co.
The information furnished with this Item 7.01, including Exhibit 99.1, shall not
be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference into any other filing under
Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as
amended, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description of Exhibit 99.1 Know Labs Presentation, 2nd Annual Bernstein CGM Disruptors Conference 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
© Edgar Online, source Glimpses